Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Oct 26, 2021 10:08pm
136 Views
Post# 34053066

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CDN biopharm company rumored for $US 7-8 Bln BMS acquisition

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CDN biopharm company rumored for $US 7-8 Bln BMS acquisition
I don't know why you make me do this and I am sure you will not apologize as you are never wrong.and for some reason you did not want to include the 2021 salary. Oh and look a little farther a 750,000 physical fitness bonus....they are not hurting too badly.
Boom gotcha

2 Amendment to the Employment Agreement
The Employment Agreement Section 3 – Remuneration is amended as follows:
(1) Commencing January 1, 2020, Oncolytics shall pay to the Employee a salary of
FIVE HUNDRED FORTY THOUSAND SEVEN HUNDRED FIFTY ($540,750.00)
CANADIAN DOLLARS per annum, exclusive of bonuses, benefits and other compensation,
payable in equal installments of TWENTY-TWO THOUSAND FIVE HUNDRED THIRTYONE
DOLLARS and TWENTY-FIVE CENTS ($22,531.25) on the 15th and last day of each
month.

2. Amendment to the Employment Agreement
The Employment Agreement Section 3 – Remuneration is amended as follows:
(1) Commencing January 1, 2021, Oncolytics shall pay to the Employee a salary of SIX
HUNDRED THIRTY-SEVEN THOUSAND TWO HUNDRED ($637,200.00) CANADIAN
DOLLARS per annum, exclusive of bonuses, benefits and other compensation, payable in equal
installments of TWENTY-SIX THOUSAND FIVE HUNDRED FIFTY DOLLARS ($26,550.00) on
the 15th and last day of each month.

SCHEDULE "B"
BENEFITS
(1) Oncolytics shall:
(a) commencing with the calendar year 2014 and annually thereafter, pay to
the Employee's Registered Retirement Savings Plan, as directed by the
Employee, an amount equal to ten (10%) percent of the Employee's
annual salary as set out in Section 3(1), not to exceed the annual
maximum allowable contribution.
(2) The Employee is presently entitled to designate an additional amount equal to a
maximum eight and a quarter (8.25%) percent of the Employee's annual salary to be
paid by Oncolytics, on a monthly basis, into an Employee Health Trust in accordance
with the provisions of the Employee Health Trust Plan currently in place, and as such
provisions may be revised from time to time.
(3) The Employee is entitled to the Physical Fitness Benefit in the amount of SEVEN
HUNDRED AND FIFTY ($750.00) CANADIAN DOLLARS per annum to use towards an
item or service that promotes physical activity; the details of which are outlined in the
Company Policy Manual.
<< Previous
Bullboard Posts
Next >>